# Immunogenicity of the Booster Dose of Two MenC Vaccines

> **NCT00392808** · PHASE4 · COMPLETED · sponsor: **Centro Superior de Investigación en Salud Publica** · enrollment: 389 (actual)

## Conditions studied

- Meningococcal Infection

## Interventions

- **BIOLOGICAL:** conjugated polysaccharide menC vaccine

## Key facts

- **NCT ID:** NCT00392808
- **Lead sponsor:** Centro Superior de Investigación en Salud Publica
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2008-05
- **Final completion:** 2009-05
- **Target enrollment:** 389 (ACTUAL)
- **Last updated:** 2013-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00392808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00392808, "Immunogenicity of the Booster Dose of Two MenC Vaccines". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00392808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*